These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19432108)

  • 21. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Utilization of metabolic markers of bone in daily osteoporosis practice].
    Miki T; Masaki H
    Clin Calcium; 2008 Aug; 18(8):1127-34. PubMed ID: 18677050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Observational studies in osteoporosis treatment].
    Giannini S; Varenna M
    Reumatismo; 2009; 61 Suppl 2():2-10. PubMed ID: 19999185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E; Eisman JA
    Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One fracture is enough! Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients.
    Astrand J; Thorngren KG; Tägil M
    Acta Orthop; 2006 Feb; 77(1):3-8. PubMed ID: 16534695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining high risk of osteoporotic fracture: a cross talk between clinical experience and guidelines recommendations.
    Casado E; Malouf J; Caamaño MM; Salas E; Sánchez-Bursón JM; Rentero ML; Herrero-Beaumont G
    J Clin Rheumatol; 2011 Aug; 17(5 Suppl 3):S59-66. PubMed ID: 23640502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intervention in lifestyle factors for the prevention of osteoporosis and osteoporotic fractures].
    Yoshimura N
    Clin Calcium; 2005 Aug; 15(8):1399-408. PubMed ID: 16062012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of fracture risk assessment tool (FRAT) by WHO study group and its proposed application].
    Nakamura T
    Clin Calcium; 2005 Aug; 15(8):1374-9. PubMed ID: 16062008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment goals of osteoporosis].
    Hosoi T
    Clin Calcium; 2014 Mar; 24(3):385-9. PubMed ID: 24576935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidisciplinary patient education in groups increases knowledge on osteoporosis: a randomized controlled trial.
    Nielsen D; Ryg J; Nissen N; Nielsen W; Knold B; Brixen K
    Scand J Public Health; 2008 Jun; 36(4):346-52. PubMed ID: 18539688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Absolute risk for fracture and WHO guideline. WHO model for assessing absolute risk of fracture].
    Iki M;
    Clin Calcium; 2007 Jul; 17(7):1015-21. PubMed ID: 17607067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis.
    Rossignol M; Moride Y; Perreault S; Boivin JF; Ste-Marie LG; Robitaille Y; Poulin de Courval L; Fautrel B
    Int J Technol Assess Health Care; 2002; 18(3):597-610. PubMed ID: 12391952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Better informed decisions in the management of osteoporosis].
    Alonso-Coello P; Bonfill X
    Reumatol Clin; 2011; 7(1):1-2. PubMed ID: 21794771
    [No Abstract]   [Full Text] [Related]  

  • 36. [FRAX: a new instrument for calculating 10-year absolute fracture risk].
    Claus-Hermberg H; Bagur A; Messina OD; Negri AL; Schurman L; Sánchez A
    Medicina (B Aires); 2009; 69(5):571-5. PubMed ID: 19897447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Diagnostic criteria of primary osteoporosis and the criteria for pharmacological treatment].
    Hosoi T
    Clin Calcium; 2015 Sep; 25(9):1279-83. PubMed ID: 26320526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines].
    Johansson H; Kanis JA; Ljunggren O; Ström O; Svensson O; Mellström D
    Lakartidningen; 2011 Feb 16-22; 108(7):336-9. PubMed ID: 21539116
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of fracture risk.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Eur J Radiol; 2009 Sep; 71(3):392-7. PubMed ID: 19716672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A personal perspective on fracture risk assessment tools.
    Ettinger B
    Menopause; 2008; 15(5):1023-6. PubMed ID: 18703988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.